| Primary |
| Product Used For Unknown Indication |
59.0% |
| Depression |
9.0% |
| Insomnia |
3.2% |
| Musculoskeletal Pain |
3.2% |
| Overdose |
3.2% |
| Intentional Overdose |
2.7% |
| Pain |
2.7% |
| Cardiac Arrest |
2.1% |
| Sleep Disorder |
2.1% |
| Fibromyalgia |
1.6% |
| Migraine Prophylaxis |
1.6% |
| Prophylaxis Of Neural Tube Defect |
1.6% |
| Borderline Personality Disorder |
1.1% |
| Depressed Mood |
1.1% |
| Essential Thrombocythaemia |
1.1% |
| Mycosis Fungoides |
1.1% |
| Myelofibrosis |
1.1% |
| Spinal Pain |
1.1% |
| Withdrawal Syndrome |
1.1% |
| Anxiolytic Therapy |
0.5% |
|
| Completed Suicide |
13.2% |
| Death |
11.8% |
| Drug Abuse |
11.8% |
| Toxicity To Various Agents |
10.3% |
| Drug Interaction |
5.9% |
| Cardio-respiratory Arrest |
4.4% |
| Hypotonia Neonatal |
4.4% |
| Myocardial Infarction |
4.4% |
| Seasonal Allergy |
4.4% |
| Supraventricular Tachycardia |
4.4% |
| Ventricular Septal Defect |
4.4% |
| Abortion Late |
2.9% |
| Gamma-glutamyltransferase Increased |
2.9% |
| Medication Error |
2.9% |
| Suicide Attempt |
2.9% |
| Unresponsive To Stimuli |
2.9% |
| Aggression |
1.5% |
| Anaemia |
1.5% |
| Aspartate Aminotransferase Increased |
1.5% |
| Atrioventricular Block Complete |
1.5% |
|
| Secondary |
| Product Used For Unknown Indication |
57.1% |
| Drug Abuse |
17.8% |
| Depression |
6.9% |
| Drug Use For Unknown Indication |
2.3% |
| Pain |
2.3% |
| Anxiety |
2.0% |
| Asthma |
1.8% |
| Suicide Attempt |
1.4% |
| Insomnia |
1.3% |
| Multiple Sclerosis |
1.0% |
| Intentional Overdose |
0.9% |
| Major Depression |
0.7% |
| Psychotic Disorder |
0.7% |
| Musculoskeletal Pain |
0.6% |
| Neuralgia |
0.6% |
| Fibromyalgia |
0.5% |
| Psoriasis |
0.5% |
| Restless Legs Syndrome |
0.5% |
| Hallucination, Visual |
0.5% |
| Ill-defined Disorder |
0.5% |
|
| Toxicity To Various Agents |
20.5% |
| Completed Suicide |
15.1% |
| Drug Abuse |
11.9% |
| Intentional Drug Misuse |
4.9% |
| Suicide Attempt |
4.9% |
| Poisoning |
4.3% |
| Delusion |
3.8% |
| Serotonin Syndrome |
3.8% |
| Cardio-respiratory Arrest |
3.2% |
| Death |
3.2% |
| Overdose |
3.2% |
| Unresponsive To Stimuli |
3.2% |
| Insomnia |
2.7% |
| Angina Pectoris |
2.2% |
| Drug Hypersensitivity |
2.2% |
| Hyperhidrosis |
2.2% |
| Intentional Overdose |
2.2% |
| Somnolence |
2.2% |
| Tachycardia |
2.2% |
| Torsade De Pointes |
2.2% |
|
| Concomitant |
| Product Used For Unknown Indication |
36.2% |
| Depression |
8.8% |
| Pain |
6.9% |
| Hypertension |
5.3% |
| Anxiety |
4.9% |
| Crohn's Disease |
4.0% |
| Drug Use For Unknown Indication |
3.3% |
| Insomnia |
3.1% |
| Bipolar Disorder |
2.9% |
| Gastrooesophageal Reflux Disease |
2.8% |
| Fibromyalgia |
2.8% |
| Sleep Disorder |
2.6% |
| Diabetes Mellitus |
2.5% |
| Asthma |
2.4% |
| Hepatitis C |
2.4% |
| Rheumatoid Arthritis |
2.4% |
| Arthritis |
1.8% |
| Osteoporosis |
1.7% |
| Psoriasis |
1.6% |
| Hormone Replacement Therapy |
1.5% |
|
| Pain |
9.5% |
| Vomiting |
9.5% |
| Weight Decreased |
9.5% |
| Somnolence |
6.6% |
| Insomnia |
5.8% |
| Vision Blurred |
5.4% |
| Weight Increased |
5.4% |
| Drug Ineffective |
5.0% |
| Wrong Technique In Drug Usage Process |
5.0% |
| Death |
4.1% |
| Urinary Tract Infection |
4.1% |
| Breast Cancer Female |
3.7% |
| Epistaxis |
3.7% |
| Fatigue |
3.3% |
| Nausea |
3.3% |
| Pruritus |
3.3% |
| Pulmonary Embolism |
3.3% |
| Renal Failure Acute |
3.3% |
| Syncope |
3.3% |
| Hypertension |
2.9% |
|
| Interacting |
| Product Used For Unknown Indication |
72.0% |
| Mental Disorder |
14.7% |
| Ill-defined Disorder |
4.9% |
| Convulsion |
2.8% |
| Depression |
2.1% |
| Arthritis |
1.4% |
| Inflammation |
1.4% |
| Epilepsy |
0.7% |
|
| Toxicity To Various Agents |
56.1% |
| Gait Disturbance |
14.6% |
| Pain |
7.3% |
| Pulmonary Oedema |
4.9% |
| Urinary Incontinence |
4.9% |
| Accidental Overdose |
2.4% |
| Drug Interaction |
2.4% |
| Oedema Peripheral |
2.4% |
| Restlessness |
2.4% |
| Type Iv Hypersensitivity Reaction |
2.4% |
|
